Canada markets closed

Inovio Pharmaceuticals, Inc. (INO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.7100-0.0600 (-3.39%)
At close: 04:00PM EDT
1.7200 +0.01 (+0.58%)
After hours: 07:48PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close1.7700
Bid1.6900 x 3000
Ask1.7100 x 1200
Day's Range1.6500 - 1.7600
52 Week Range1.3800 - 7.9000
Avg. Volume5,843,120
Market Cap426.474M
Beta (5Y Monthly)0.82
PE Ratio (TTM)N/A
EPS (TTM)-1.5420
Earnings DateNov 07, 2022 - Nov 11, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.20
  • Motley Fool

    1 Green Flag and 1 Red Flag For Inovio Pharmaceuticals

    Developing innovative products is an excellent way for a company to become successful, and that's what Inovio Pharmaceuticals (NASDAQ: INO) is looking to do. Let's look at one reason Inovio could be an exciting contrarian buy, and one reason to stay away. Small-cap biotechs need promising pipeline programs to attract attention.

  • Zacks

    Emergent (EBS) Initiates Study on Lassa Virus Vaccine Candidate

    Emergent BioSolutions (EBS) initiates an early-stage study evaluating its Lassa virus vaccine candidate, EBS-LASV, for the prevention of Lassa fever.

  • Motley Fool

    Why Inovio Pharmaceuticals Is Gaining Today

    Inovio Pharmaceuticals' (NASDAQ: INO) stock rose by more than 18.5% as of 2:30 p.m. ET on Wednesday after the company's Q2 earnings results broke the news of its plans to restructure its operations to conserve cash. The biotech will lay off 18% of its full-time employees while additionally reducing its contractor head count by a massive 86%. Inovio also announced the appointment of a new chief medical officer, Dr. Michael Sumner, which might be another contributing factor to the gain of its stock today.